 |
 |

Immunotherapy and Asthma
J. Mark Fitzgerald, MB, MRCPI, FRCPC
St Joseph's Hospital McMaster University Hamilton, Canada
JAMA. 1989;262(13):1772.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
I note with interest the recent article1 regarding the role of intravenous corticosteroids in status asthmaticus. The article makes a useful contribution in elucidating the appropriate dose and mode of administration of corticosteroids in acute asthma. Despite this, I think it would be appropriate for the authors to comment on the fact that at the time of entry to the study, 21% of the patients in the oral group as against 11% of the patients in the intravenous group were taking steroids (Table 1 of the article). I think this could introduce a bias in the study, as patients who had started therapy before randomization might have had a significant effect on outcome. In addition, the authors fail to mention a previous study that supports their hypothesis.2
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|